We are live on ! Find out more
HA

HHLR Advisors Portfolio holdings

AUM $832M
1-Year Est. Return 32.38%
This Fund
S&P 500
This Quarter Est. Return
-6.55%
1 Year Est. Return
+32.38%
3 Year Est. Return
+137.31%
5 Year Est. Return
+86.76%
10 Year Est. Return
–
AUM
$4.6B
AUM Growth
-$358M
Cap. Flow
+$124M
Cap. Flow %
2.69%
Top 10 Hldgs %
84.57%
Holding
69
New
20
Increased
2
Reduced
18
Closed
6
Avg Time Held
7.5 quarters
Top 10 Avg Time Held
6.4 quarters
Top 20 Avg Time Held
6.5 quarters

Top Sells

Rank Stock Value
1
CRM icon
Salesforce
CRM
+$82.3M
2
BABA icon
Alibaba
BABA
+$78.9M
3
RYZB icon
RayzeBio, Inc. Common Stock
RYZB
+$66M
4
DASH icon
DoorDash
DASH
+$52.9M
5
BIDU icon
Baidu
BIDU
+$41M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 36.91%
2 Healthcare 33.02%
3 Technology 15.02%
4 Real Estate 8.7%
5 Communication Services 3.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
PDD icon
1
Pinduoduo
PDD
$115B
$1.37B 29.77%
11,791,547
+1,680,600
+17% +$220M
2022 Q2
7 quarters
ONC icon
2
BeOne Medicines Ltd
ONC
$39.7B
$810M 17.58%
5,176,906
– –
2018 Q4
21 quarters
BEKE icon
3
KE Holdings
BEKE
$19.3B
$401M 8.7%
29,181,868
-42,700
-0.1% -$597K
2020 Q3
14 quarters
LEGN icon
4
Legend Biotech
LEGN
$3.57B
$336M 7.29%
5,984,550
– –
2020 Q2
15 quarters
MSFT icon
5
Microsoft
MSFT
$4.02T
$291M 6.32%
692,100
-37,300
-5% -$15.1M
2022 Q2
7 quarters
AMD icon
6
Advanced Micro Devices
AMD
$972B
$165M 3.58%
+912,400
New +$159M
2024 Q1
0 quarters
AMZN icon
7
Amazon
AMZN
$2.83T
$148M 3.22%
822,900
+11,000
+1% +$1.84M
2022 Q2
7 quarters
CRM icon
8
Salesforce
CRM
$197B
$139M 3.02%
462,137
-285,400
-38% -$82.3M
2020 Q1
16 quarters
DHR icon
9
Danaher
DHR
$155B
$118M 2.56%
471,100
– –
2023 Q2
3 quarters
TTWO icon
10
Take-Two Interactive
TTWO
$39.8B
$116M 2.53%
783,000
– –
2023 Q2
3 quarters
DASH icon
11
DoorDash
DASH
$84.5B
$80.4M 1.75%
583,463
-449,300
-44% -$52.9M
2020 Q4
13 quarters
AVBP icon
12
ArriVent BioPharma
AVBP
$812M
$70.2M 1.52%
+3,929,117
New +$79.3M
2024 Q1
0 quarters
KNSA icon
13
Kiniksa Pharmaceuticals
KNSA
$6.21B
$61.9M 1.34%
+3,135,735
New +$61.2M
2024 Q1
0 quarters
MCO icon
14
Moody's
MCO
$81.1B
$61.3M 1.33%
155,846
– –
2023 Q4
1 quarter
ENFN icon
15
DELISTED
Enfusion, Inc.
ENFN
$46M 1%
4,975,183
– –
2021 Q4
9 quarters
CTKB icon
16
Cytek Biosciences
CTKB
$697M
$44.7M 0.97%
6,657,030
– –
2021 Q3
10 quarters
BBIO icon
17
BridgeBio Pharma
BBIO
$12.8B
$42.3M 0.92%
1,367,489
-23,751
-2% -$808K
2019 Q2
19 quarters
HTHT icon
18
Huazhu Hotels Group
HTHT
$13.8B
$36.2M 0.79%
935,920
– –
2020 Q2
15 quarters
CPNG icon
19
Coupang
CPNG
$28B
$19.1M 0.41%
1,071,500
-1,146,300
-52% -$18.8M
2021 Q3
10 quarters
BIDU icon
20
Baidu
BIDU
$28.4B
$15.9M 0.34%
150,600
-384,800
-72% -$41M
2023 Q1
4 quarters
NTES icon
21
NetEase
NTES
$80.6B
$15.5M 0.34%
149,700
– –
2022 Q4
5 quarters
YSG icon
22
Yatsen Holding
YSG
$242M
$14.7M 0.32%
6,987,839
-1
-0% -$3
2020 Q4
13 quarters
ONON icon
23
On Holding
ONON
$11.7B
$14.6M 0.32%
411,400
– –
2021 Q3
10 quarters
MDLZ icon
24
Mondelez International
MDLZ
$77.4B
$13.7M 0.3%
196,288
-173,900
-47% -$12.7M
2018 Q4
21 quarters
ZTO icon
25
ZTO Express
ZTO
$15.1B
$13.7M 0.3%
654,524
-160,000
-20% -$3.06M
2023 Q1
4 quarters

Similar funds

HHLR Advisors's Q1 2024 Portfolio in Review

As of Q1 2024, HHLR Advisors held 69 positions worth $4.6B, down 7.2% from $4.96B the previous quarter. Its ten largest holdings account for 85% of the portfolio.

HHLR Advisors's Q1 2024 filing shows 20 new, 2 increased, 18 reduced and 6 closed positions. Its largest new stake was Advanced Micro Devices: 912,400 shares worth $165M. The largest sale was Salesforce, an estimated $82.3M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 37% of assets, down from 39% a quarter earlier, followed by Healthcare and Technology.

  • HHLR Advisors's largest Q1 2024 buy was Advanced Micro Devices: 912,400 shares worth $165M.
  • HHLR Advisors added most to Pinduoduo in Q1 2024, an estimated $220M increase.
  • HHLR Advisors's biggest Q1 2024 reduction was Salesforce, cutting an estimated $82.3M.
  • HHLR Advisors fully exited RayzeBio, Inc. Common Stock in Q1 2024, selling an estimated $66M.
  • HHLR Advisors's ten largest holdings make up 85% of its $4.6B portfolio in Q1 2024.
  • HHLR Advisors opened 20 new positions and closed 6 in Q1 2024.
  • HHLR Advisors's portfolio value fell 7.2% quarter-over-quarter to $4.6B.

Based on HHLR Advisors's 13F filing for Q1 2024, filed 14 May 2024.